[Results of radiation therapy for optic nerve sheath meningioma]. / Rezul'taty luchevogo lecheniya meningiomy obolochki zritel'nogo nerva.
Vestn Oftalmol
; 138(5): 5-13, 2022.
Article
in Ru
| MEDLINE
| ID: mdl-36288412
ABSTRACT
Optic nerve sheath meningioma (ONSM) is a slow-growing benign tumor that tends to extend intracranially. The tumor is characterized by vision disturbance, optic nerve atrophy and edema. At present, radiotherapy is recommended as the treatment of choice for ONSM. PURPOSE:
To assess the neuro-ophthalmic symptomatology of ONSM and how it changes in response to radiotherapy. MATERIAL ANDMETHODS:
In the period from 2004 to 2018, 112 patients with ONSM aged 17 to 76 years underwent stereotactic radiotherapy. In 91 patients, visual functions varied from light perception to 1.0; in 21 patients the affected eye was blind. The prospective follow-up of 103 patients lasted 6 months to 10 years (mean follow-up duration was 57 months). Studied patients underwent either conventional fractionated radiotherapy with Novalis (n=88) or hypofractionation radiotherapy with CyberKnife (n=24).RESULTS:
According to ophthalmological examination, in 60.5% of cases an improvement of visual functions was observed, 39.5% of patients had visual functions remain stable at the initial level. No vision impairment during irradiation was detected. Vision deterioration in the long-term follow-up was observed in 2 patients extended tumor growth in one case and radio-induced retinopathy in the other.CONCLUSION:
The study showed that this method of treatment for ONSM is effective and safe, allowing preservation of visual functions and in some cases - its improvement, while tumor growth remains under control.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Optic Nerve Neoplasms
/
Meningeal Neoplasms
/
Meningioma
Type of study:
Diagnostic_studies
/
Observational_studies
Limits:
Humans
Language:
Ru
Journal:
Vestn Oftalmol
Year:
2022
Document type:
Article
Affiliation country:
Rusia